Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Foster City, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Mirum Pharmaceuticals, Inc. has filed 663 SEC EDGAR filings since 20 Nov 2018

SEC filing history

Showing 576-600 of 663 matching filings.

Per page
25
Current page
24
8-K File 001-38981

8-K

Filing date
06 Nov 2019
Reporting date
06 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Oct 2019
Reporting date
24 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
28 Oct 2019
Reporting date
24 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Sep 2019
Reporting date
16 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Sep 2019
Reporting date
10 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Sep 2019
Reporting date
06 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Sep 2019
Reporting date
06 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Sep 2019
Reporting date
06 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Sep 2019
Reporting date
06 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91075

SC 13G

Filing date
10 Sep 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-233502

S-8

Filing date
28 Aug 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38981

FORM 8-K

Filing date
28 Aug 2019
Reporting date
28 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91075

SC 13D

Filing date
01 Aug 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91075

NEW ENTERPRISE ASSOCIATES 16, L.P. - MIRUM PHARMACEUTICALS, INC. 13D

Filing date
30 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91075

SCHEDULE 13D

Filing date
26 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38981

8-K

Filing date
25 Jul 2019
Reporting date
22 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Jul 2019
Reporting date
22 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Jul 2019
Reporting date
22 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Jul 2019
Reporting date
22 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Jul 2019
Reporting date
22 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Jul 2019
Reporting date
22 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Jul 2019
Reporting date
22 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Jul 2019
Reporting date
22 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Jul 2019
Reporting date
22 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .